Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:55:00 2025-07-09 am EDT			After hours 03:48:53 pm
59.70 ^EUR	+0.03%		59.32	-0.64%

Jun. 27	Eurofins: completes E500m bond issue	CF
Jun. 27	French and Benelux stocks-Factors to watch	RE

Eurofins: issues a new hybrid bond

Published on 03/26/2025 at 06:04

Eurofins Scientific announces its intention to issue a new €400m hybrid bond, while launching a tender offer for its €400m 3.250% hybrid bond with a first redemption date in November 2025.

This offer is subject to the successful issue of the new hybrid bond. Any hybrid bond 2025 validly tendered will be accepted for redemption. The results of the offer are expected to be announced on 3 April.

The bio-analytical services group explains that these transactions are intended to proactively manage the refinancing of its outstanding hybrid instruments and to increase the average life of its financing instruments.

Latest news about Eurofins Scientific SE

Eurofins: completes E500m bond issue	Jun. 27	CF
French and Benelux stocks-Factors to watch	Jun. 27	RE
Eurofins Scientific Issues EUR500 Million Schuldschein Loan	Jun. 27	MT
Eurofins Scientific SE Announces the Success of Its New Schuldschein Issuance of ?500 Million to Refinance Its 2025 Schuldschein Loans	Jun. 26	CI
Eurofins Scientific SE acquired PLANTON GmbH from Michael Kleine and others.	May. 19	CI
The stock market has just gained 15% but remains in the fog	Apr. 30
Five sessions of gains in Trump's first 100 days	Apr. 29
The stock market returns to "Risk On"	Apr. 25
HSBC Downgrades Eurofins Scientific to Hold, Cuts PT	Apr. 25	MT
Eurofins Scientific SE commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 24, 2025.	Apr. 25	CI
Eurofins Scientific To Buy Back Max. 4.5% Of Its Shares	Apr. 25	RE
Eurofins Scientific SE 's Equity Buyback announced on September 2, 2024 has expired.	Apr. 23	CI
EUROFINS SCIENTIFIC : Reiterated outlook impresses investors	Apr. 23
Eurofins Scientific SE, Q1 2025 Sales/ Trading Statement Call, Apr 23, 2025	Apr. 23
Eurofins: Q1 sales up nearly 7%	Apr. 23	CF
Eurofins Q1 Revenues At EUR 1.77 Bln	Apr. 23	RE
Tranche Update on Eurofins Scientific SE's Equity Buyback Plan announced on September 2, 2024.	Apr. 23	CI
Eurofins: completes refinancing of hybrid bonds	Apr. 03	CF
Eurofins Announces the Success of Its Tender Offer on Its ?400 Million Hybrid Bond	Apr. 03	CI
EUROFINS : Jefferies still a seller, but raises TP	Apr. 01	CF
Eurofins Scientific Completes Purchase of Synlab's Spanish Clinical Diagnostics Operations	Apr. 01	MT
Eurofins: acquisition of Synlab business in Spain	Apr. 01	CF
Eurofins Scientific Closes Acquisition Of SYNLAB's Clinical Diagnostics Operations In Spain	Apr. 01	RE
Eurofins Scientific SE completed the acquisition of clinical diagnostics operations in Spain from SYNLAB AG.	Mar. 30	CI
Eurofins: successful hybrid bond issue	Mar. 28	CF

Chart Eurofins Scientific SE

Duration

Period

ERF: Dynamic Chart

Company Profile

Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2024, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 950 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (51%), North America (38.3%) and other (10.7%).

Employees

62,696

Sector

Biotechnology & Medical Research

Calendar

Jul. 22 - Q2 2025 Earnings Release

More about the company